Professor Noel Clarke 

2009

• McRonald, F, Morris, M, Gentle, D, Winchester, L, Baban, D, Ragoussis, J, Clarke, N, Brown, MD, Kishida, T, Yao, M, Latif, F, Maher, E. (2009). CpG Methylation Profiling in VHL related and VHL unrelated Renal Cell Carcinoma. Molecular Cancer, 8(31), eScholarID:1d19258 | DOI:10.1186/1476-4598-8-31
• Sinclair et al. (2009). British Journal of Medical and Surgical Urology. National re-audit of urology outpatient practice in the UK, eScholarID:124122

2008

• Addla SK, Brown MD, Hart C, Ramani V, Clarke N. (2008). Characterization of the Hoechst33342 side population from normal and malignant human renal epithelial cells. Am J Physiol Renal Physiol, 295(3), F680-F687. eScholarID:1d17555 | DOI:10.1152/ajprenal.90286.2008
• Baker M, Michael Brown, Gazi E, Clarke N, Vickerman John, Lockyer Nicholas. (2008). Discrimination of prostate cancer cells and non-malignant cells using secondary ion mass spectrometry. The Analyst, 133(2), 175-179. eScholarID:1d16822 | DOI:10.1039/b712853c
• Ben Grey, Jeremy Oates, Brown MD, Clarke N. (2008). CD133: A MARKER OF TRANSIT AMPLIFICATION RATHER THANSTEM CELL PHENOTYPE IN THE PROSTATE? BJU International, 103(7), 856-858. eScholarID:1d18211 | DOI:10.1111/j.1464-410X.2008.08250.x
• Harvey T, Faria E, Henderson A, Gazi EE, Ward A, Clarke N, Brown MD, Snook R, Gardner P. (2008). Spectral discrimination of live prostate and bladder cancer cell lines using Raman optical tweezers. J Biomed Opt, 13(6), eScholarID:1d32528 | DOI:10.1117/1.2999609
• Morris, M, Gentle, D, Abdulrahman, M, Clarke, N, Brown, MD, Kishida, T, Yao, M, Teh, B, Latif, F, Maher, E. (2008). Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma. Br J Cancer, 98(2), 456-501. eScholarID:1d16846 | DOI:10.1038/sj.bjc.6604180

2007

• Brown MD, Gilmore P, Hart CA, Samuel J, Ramani V, George NN J, Clarke N. (2007). Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations. Prostate, 67(13), 1384-1396. eScholarID:1d16051 | DOI:10.1002/pros.20620
• Clarke N, Brown MD. (2007). The Influence of Lipid Metabolism on Prostate Cancer Development and Progression: Is it Time for a Closer Look? European Urology, 52(1), 3-4. eScholarID:1d15845 | DOI:10.1016/j.eururo.2007.04.039
• Gazi E, Dwyer J, Lockyer NP, Gardner P, Shanks JH, Roulson J, Hart CA, Clarke N, Brown MD. (2007). Biomolecular profiling of metastatic prostate cancer cells in bone marrow tissue using FTIR microspectroscopy: a pilot study. Anal Bioanal Chem, 387(5), 1621-1631. eScholarID:1d15133 | DOI:10.1007/s00216-006-1093-y
• Gazi E, Gardner P, Lockyer NP, Hart CA, Brown MD, Clarke N. (2007). Direct evidence of lipid translocation between adipocytes and prostate cancer cells with imaging FTIR microspectroscopy. J Lipid Res, 48(8), 1846-1856. eScholarID:1d15844 | DOI:10.1194/jlr.M700131-JLR200
• Harvey T, Henderson A, Gazi E, Clarke N, Brown MD, Faria E, Snook R, Gardner P. (2007). Discrimination of prostate cancer cells by reflection mode FTIR photoacoustic spectroscopy. Analyst, 132(4), 292-295. eScholarID:1d15896 | DOI:10.1039/b618618a
• Lee J, Gazi E, Dwyer J, Brown MD, Clarke N, Nicholson J, Gardner P. (2007). Optical artefacts in transflection mode FTIR microspectroscopic images of single cells on a biological support: the effect of back-scattering into collection optics. Analyst, 132(8), 750-755. eScholarID:1d16059 | DOI:10.1039/b702064c

2006

• Brown MD, Hart CA, Gazi E, Bagley SS, Clarke N. (2006). Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs. Br J Cancer, 94(6), 842-853. eScholarID:1d13012 | DOI:10.1038/sj.bjc.6603030
• Gazi, E, Baker, M, Dwyer, J, Lockyer, N, Gardner, P, Shanks, J, Reeve, R, Hart, CA, Clarke, N, Brown, MD, Brown, MD. (2006). A Correlation of FTIR Spectra Derived from Prostate Cancer Biopsies with Gleason Grade and Tumour Stage. Eur Urol, 50(4), 750-60. eScholarID:1d13010

2005

• Hart CA, Brown MD, Bagley SS, Sharrard M, Clarke N. (2005). Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process. Br J Cancer, 92(3), 503-512. eScholarID:1d12072 | DOI:10.1038/sj.bjc.6602325
• Maddineni S, Sangar V, Hendry J, Margison GP, Clarke N. (2005). Differential radiosensitisation by ZD1839 (Iressa), a highly selective epidermal growth factor receptor tyrosine kinase inhibitor in two related bladder cancer cell lines. Br J Cancer, 92( 1), 125-30. eScholarID:1d28931

2001

• McIntyre IG, Clarke RB, Anderson E, Clarke N, George NN J. (2001). Molecular prediction of progression of prostate cancer in conservatively managed patients. Urology, 58, eScholarID:1d2638